Tourmaline Bio, Inc. (TRML)

Tourmaline Bio Stock Forecast

Stock Price Forecast

The 12 analysts that cover Tourmaline Bio stock have a consensus rating of "Hold" and an average price target of $47.04, which forecasts a -1.96% decrease in the stock price over the next year. The lowest target is $25 and the highest is $58.

Price Target: $47.04 (-1.96%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$25	$47.04	$48	$58
Change	-47.89%	-1.96%	+0.04%	+20.88%

* Price targets were last updated on Sep 15, 2025.

Analyst Ratings

The average analyst rating for Tourmaline Bio stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	May '25	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25
Strong Buy	3	3	3	3	0	0
Buy	4	4	4	4	3	3
Hold	0	0	0	0	9	9
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kostas Biliouris BMO Capital	BMO Capital	Buy → Hold Downgrades $35 → $48	Buy → Hold	Downgrades	$35 → $48	+0.04%	Sep 15, 2025
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy → Hold Downgrades $65 → $48	Buy → Hold	Downgrades	$65 → $48	+0.04%	Sep 11, 2025
Robyn Karnauskas Truist Securities	Truist Securities	Strong Buy → Hold Downgrades $63 → $48	Strong Buy → Hold	Downgrades	$63 → $48	+0.04%	Sep 10, 2025
Yatin Suneja Guggenheim	Guggenheim	Strong Buy → Hold Downgrades $55 → $48	Strong Buy → Hold	Downgrades	$55 → $48	+0.04%	Sep 10, 2025
Daniil Gataulin Chardan Capital	Chardan Capital	Strong Buy → Hold Downgrades $70 → $48	Strong Buy → Hold	Downgrades	$70 → $48	+0.04%	Sep 10, 2025

More Analyst Ratings

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  n/a
• EPS This Year:
  -3.83

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	10.20M
Revenue Growth	-	-	-	-	-	-	-
EPS	-0.08	-22.46	-8.87	-2.89	-3.83	-4.17	-4.64
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	10	9	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-3.78	-3.56
Avg	-3.83	-4.17
Low	-4.01	-4.55

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.